Glucose amplification of forward signalling from β-cell ephrinA to α-cell EphA4 receptors was recently proposed to complement paracrine inhibition of glucagon release (Figure 2) and explain glucagon hypersecretion when β-cells disappear in diabetes (78). This evidence concerns the gene GCG and diabetes mellitus.